Casdin Capital, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.24 Billion distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Revolution Medicines, Inc. with a value of $181M, Standard Biotools Inc. with a value of $168M, Biolife Solutions Inc with a value of $162M, Sarepta Therapeutics, Inc. with a value of $138M, and Relay Therapeutics, Inc. with a value of $61.6M.
Examining the 13F form we can see an increase of $284M in the current position value, from $955M to 1.24B.
Casdin Capital, LLC is based out at New York, NY
Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.